Bioptik Technology (4161) — Financial Flexibility Index
Bioptik Technology (4161) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of NT$58.15 Million (operating CF NT$53.21 Million minus capex NT$4.94 Million) represents 0% of total liabilities (NT$597.14 Million). Check Bioptik Technology strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioptik Technology Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Bioptik Technology across 9 annual periods. See working capital to net assets of Bioptik Technology to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bioptik Technology (2017–2025)
Year-by-year free cash flow to debt coverage for Bioptik Technology. For the full company profile including market capitalisation, see 4161 market cap.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | NT$82.79 Million | NT$59.99 Million | NT$597.14 Million | ▼ -53.7% |
| 2024 | 0.30x | NT$174.33 Million | NT$158.82 Million | NT$582.47 Million | ▼ -14.9% |
| 2023 | 0.35x | NT$236.99 Million | NT$205.95 Million | NT$673.56 Million | ▲ +288.9% |
| 2022 | 0.09x | NT$72.14 Million | NT$55.06 Million | NT$797.40 Million | ▲ +451.8% |
| 2021 | -0.03x | NT$-21.33 Million | NT$-41.15 Million | NT$829.38 Million | ▼ -196.1% |
| 2020 | 0.03x | NT$19.75 Million | NT$6.57 Million | NT$738.10 Million | ▼ -69.3% |
| 2019 | 0.09x | NT$68.46 Million | NT$41.03 Million | NT$786.05 Million | ▼ -25.7% |
| 2018 | 0.12x | NT$92.78 Million | NT$41.83 Million | NT$792.07 Million | ▲ +7.7% |
| 2017 | 0.11x | NT$73.74 Million | NT$11.02 Million | NT$678.08 Million | — |